3hi6: Difference between revisions
No edit summary |
No edit summary |
||
Line 32: | Line 32: | ||
==See Also== | ==See Also== | ||
*[[Introduction to Evolutionary Conservation|Introduction to Evolutionary Conservation]] | *[[Introduction to Evolutionary Conservation|Introduction to Evolutionary Conservation]] | ||
*[[Introduction to Evolutionary Conservation (Spanish)|Introduction to Evolutionary Conservation (Spanish)]] | *[[Introduction to Evolutionary Conservation (Spanish)|Introduction to Evolutionary Conservation (Spanish)]] | ||
Line 43: | Line 42: | ||
[[Category: Wang, J]] | [[Category: Wang, J]] | ||
[[Category: Zhang, H]] | [[Category: Zhang, H]] | ||
[[Category: Alternative splicing]] | |||
[[Category: Calcium]] | |||
[[Category: Cell adhesion]] | [[Category: Cell adhesion]] | ||
[[Category: Cell adhesion-immune system complex]] | [[Category: Cell adhesion-immune system complex]] | ||
Line 53: | Line 54: | ||
[[Category: Magnesium]] | [[Category: Magnesium]] | ||
[[Category: Membrane]] | [[Category: Membrane]] | ||
[[Category: Polymorphism]] | |||
[[Category: Receptor]] | [[Category: Receptor]] | ||
[[Category: Transmembrane]] | [[Category: Transmembrane]] |
Revision as of 10:37, 1 November 2017
Crystal structure of intermediate affinity I domain of integrin LFA-1 with the Fab fragment of its antibody AL-57Crystal structure of intermediate affinity I domain of integrin LFA-1 with the Fab fragment of its antibody AL-57
Structural highlights
Function[ITAL_HUMAN] Integrin alpha-L/beta-2 is a receptor for ICAM1, ICAM2, ICAM3 and ICAM4. It is involved in a variety of immune phenomena including leukocyte-endothelial cell interaction, cytotoxic T-cell mediated killing, and antibody dependent killing by granulocytes and monocytes. Evolutionary Conservation![]() Check, as determined by ConSurfDB. You may read the explanation of the method and the full data available from ConSurf. Publication Abstract from PubMedThe activity of integrin LFA-1 (alpha(L)beta(2)) to its ligand ICAM-1 is regulated through the conformational changes of its ligand-binding domain, the I domain of alpha(L) chain, from an inactive, low-affinity closed form (LA), to an intermediate-affinity form (IA), and then finally, to a high-affinity open form (HA). A ligand-mimetic human monoclonal antibody AL-57 (activated LFA-1 clone 57) was identified by phage display to specifically recognize the affinity-upregulated I domain. Here, we describe the crystal structures of the Fab fragment of AL-57 in complex with IA, as well as in its unligated form. We discuss the structural features conferring AL-57's strong selectivity for the high affinity, open conformation of the I domain. The AL-57-binding site overlaps the ICAM-1 binding site on the I domain. Furthermore, an antibody Asp mimics an ICAM Glu by forming a coordination to the metal-ion dependent adhesion site (MIDAS). The structure also reveals better shape complementarity and a more hydrophobic interacting interface in AL-57 binding than in ICAM-1 binding. The results explain AL-57's antagonistic mimicry of LFA-1's natural ligands, the ICAM molecules. Structural basis of activation-dependent binding of ligand-mimetic antibody AL-57 to integrin LFA-1.,Zhang H, Liu JH, Yang W, Springer T, Shimaoka M, Wang JH Proc Natl Acad Sci U S A. 2009 Oct 27;106(43):18345-50. Epub 2009 Sep 23. PMID:19805116[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See Also
References |
|